Tower Research Capital LLC (Trc) Ocugen, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Ocugen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 39,848 shares of OCGN stock, worth $27,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,848

Previous 9,728 309.62%

Holding current value

$27,096

Previous $9,000 244.44%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.72 - $1.08 $21,686 - $32,529	30,120 Added 309.62%	39,848 $31,000
Q3 2024 Nov 14, 2024	SELL	$0.98 - $1.95 $6,723 - $13,378	-6,861 Reduced 41.36%	9,728 $9,000
Q2 2024 Aug 13, 2024	BUY	$1.18 - $1.98 $2,262 - $3,795	1,917 Added 13.07%	16,589 $25,000
Q1 2024 May 15, 2024	BUY	$0.5 - $1.83 $7,136 - $26,117	14,272 Added 3568.0%	14,672 $24,000
Q4 2023 Feb 13, 2024	SELL	$0.36 - $0.57 $1,450 - $2,296	-4,029 Reduced 90.97%	400 $0
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $2,564 - $3,974	-6,410 Reduced 59.14%	4,429 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $29,068 - $56,844	-64,596 Reduced 85.63%	10,839 $5,000
Q1 2023 May 09, 2023	BUY	$0.82 - $1.33 $32,327 - $52,433	39,424 Added 109.48%	75,435 $64,000
Q4 2022 Feb 10, 2023	SELL	$1.11 - $1.87 $100,403 - $169,148	-90,454 Reduced 71.52%	36,011 $47,000
Q3 2022 Nov 10, 2022	BUY	$1.75 - $3.1 $99,828 - $176,839	57,045 Added 82.17%	126,465 $225,000
Q2 2022 Aug 15, 2022	BUY	$1.83 - $3.45 $37,866 - $71,387	20,692 Added 42.46%	69,420 $157,000
Q1 2022 May 12, 2022	SELL	$2.34 - $4.72 $45,276 - $91,327	-19,349 Reduced 28.42%	48,728 $161,000
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $47,632 - $170,411	10,875 Added 19.01%	68,077 $309,000
Q3 2021 Nov 15, 2021	BUY	$6.36 - $8.51 $304,389 - $407,288	47,860 Added 512.31%	57,202 $411,000
Q2 2021 Aug 16, 2021	BUY	$5.52 - $15.68 $44,204 - $125,565	8,008 Added 600.3%	9,342 $75,000
Q1 2021 May 17, 2021	SELL	$1.66 - $15.81 $28,744 - $273,765	-17,316 Reduced 92.85%	1,334 $9,000
Q4 2020 Feb 16, 2021	BUY	$0.28 - $2.6 $5,222 - $48,490	18,650 New	18,650 $34,000

Others Institutions Holding OCGN

# of Institutions

123

Shares Held

68.6M

Call Options Held

478K

Put Options Held

253K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $147M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Ocugen, Inc. Transaction History